Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae120 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Huixiao Wu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, Chi…. Hauptthemen laut MEDLINE: Familial Hypophosphatemic Rickets, PHEX Phosphate Regulating Neutral Endopeptidase. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Key R&D Program, National Key Research and Development Project.
Abstract (Originalsprache)
Background
X-linked hypophosphatemia (XLHR) is the most common genetic form of hypophosphatemic rickets (HR), which is caused by phosphate regulating endopeptidase homolog X-linked (PHEX) gene mutation. At present, the genotype–phenotype relationship of XLHR and the pathogenic role of PHEX are not fully understood.
Methods
In this study, we summarized clinical features in a new cohort of 49 HR patients and detected 16 novel PHEX and 5 novel non-PHEX variants. Subsequently, we studied the pathogenesis of new variants by protein expression, glycosylation analysis, subcellular localization, and endopeptidase activity.
Results
The results showed that missense variants (Q189H and X750R) slightly reduced protein expression without obviously altering protein length and localization, whereas truncating variants significantly impaired the synthesis of PHEX and produced a shorter immature protein in cells. Interestingly, no evident correlation was observed between mutation types and clinical phenotypes. However, when we analyzed the relationship between PHEX activity and serum phosphorus level, we found that patients with low PHEX activity tended to have severe hypophosphatemia and high rickets severity score. Following this observation, we established 2 new knock-in XLHR mouse models with 2 novel Phex variants (c.T1349C and c.C426G, respectively) using CRISPR/Cas9 technology. Both mouse models demonstrated clinical manifestations of XLHR seen in patients, and PhexC426G mice showed more severe phenotype than PhexT1349C mice, which further confirmed the rationality of genotype–PHEX enzymatic activity correlation analysis.
Conclusion
Therefore, our findings demonstrated that novel PHEX variants could disrupt protein function via affecting protein synthesis, post-translational modification, cellular trafficking, and catalytic activity. Our study facilitates a better understanding of XLHR pathogenic mechanism and PHEX activity-phenotype correlation, which is of crucial importance for future diagnosis and treatment of XLHR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.
- Department of Endocrinology and Metabolism, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China.
- Institute of Endocrinology, Shandong Academy of Clinical Medicine, Jinan 250021, Shandong, China.
- Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan 250021, Shandong, China.
- Department of Pediatric, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.
- Department of Pediatric Orthopedics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China.
ORCID-Profile: Jiajun Zhao, Chao Xu
Förderung
- National Natural Science Foundation of China
- Shandong Key R&D Program
- National Key Research and Development Project
- Shandong First Medical University
Zitieren
APA
Wu, H., Ying, H., Zhao, W., Sun, Y., Wang, Y., Chen, X., Li, G., Yao, Y., Xu, S., Li, T., Fang, L., Sun, X., Wang, N., Xu, J., Guan, Q., Xia, W., Wang, L., Gao, L., Zhao, J., & Xu, C. (2024). Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae120
Vancouver
Wu H, Ying H, Zhao W, Sun Y, Wang Y, Chen X, et al. Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae120
BibTeX
@article{Wu2024,
author = {Wu, Huixiao and Ying, Hui and Zhao, Wanyi and Sun, Yan and Wang, Yanzhou and Chen, Xinyu and Li, Guimei and Yao, Yangyang and Xu, Shuo and Li, Tianyou and Fang, Li and Sun, Xiaoqing and Wang, Ning and Xu, Jin and Guan, Qingbo and Xia, Weibo and Wang, Li and Gao, Ling and Zhao, Jiajun and Xu, Chao},
title = {Characterization of Novel PHEX Variants in X-linked Hypophosphatemic Rickets and Genotype-PHEX Activity Correlation},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae120}
}
EUVIMED